DR1 (down-regulator of transcription 1)

symbol:
DR1
locus group:
protein-coding gene
location:
1p22.1
gene_family:
alias symbol:
NC2-BETA|NC2B|NCB2
alias name:
negative cofactor 2|negative cofac…
entrez id:
1810
ensembl gene id:
ENSG00000117505
ucsc gene id:
uc001dpu.4
refseq accession:
NM_001938
hgnc_id:
HGNC:3017
approved reserved:
1996-07-11
1p22.1

DR1(也称为TATA-binding protein-associated factor 1B或TAF1B)是一个编码蛋白质的基因,属于TATA结合蛋白相关因子(TAF)家族的一部分。这个基因家族的主要共性是参与转录起始复合物的形成,特别是与RNA聚合酶I相关的转录调控。DR1基因编码的蛋白质是RNA聚合酶I转录系统的重要组成部分,负责调控核糖体RNA(rRNA)的合成,从而影响细胞生长和增殖。DR1蛋白通过与TATA结合蛋白(TBP)和其他转录因子相互作用,帮助组装转录起始复合物,确保rRNA基因的高效表达。 DR1基因的突变可能会破坏其正常功能,导致rRNA合成减少,进而影响核糖体的生物合成和蛋白质翻译。这种功能缺陷可能引发细胞增殖异常,甚至与某些癌症或发育障碍相关。研究表明,DR1的表达水平异常(如过表达或降低表达)可能影响细胞的生长速率。过表达DR1可能导致rRNA过度合成,促进细胞异常增殖,可能与肿瘤发生有关;而DR1表达降低则可能抑制细胞生长,导致增殖迟缓或凋亡增加。 此外,DR1还与其他基因和信号通路相互作用,例如与p53肿瘤抑制蛋白的调控网络有关联。在某些癌症中,DR1的表达水平可能作为潜在的生物标志物或治疗靶点。由于DR1在核糖体生物合成中的关键作用,其功能异常可能影响多种细胞过程,包括代谢、应激反应和细胞周期调控。 总的来说,DR1基因在维持细胞稳态和增殖中发挥重要作用,其表达水平的异常可能对机体产生广泛影响,尤其是与癌症和发育相关的疾病。该基因所在的TAF家族成员普遍参与转录调控,但DR1更专注于RNA聚合酶I介导的rRNA合成,体现了基因家族功能的分工与协作。

ChineseEnglish

This gene encodes a TBP- (TATA box-binding protein) associated phosphoprotein that represses both basal and activated levels of transcription. The encoded protein is phosphorylated in vivo and this phosphorylation affects its interaction with TBP. This protein contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region. The binding of DR1 repressor complexes to TBP-promoter complexes may establish a mechanism in which an altered DNA conformation, together with the formation of higher order complexes, inhibits the assembly of the preinitiation complex and controls the rate of RNA polymerase II transcription. [provided by RefSeq, Jul 2008]

Nucleotide sequence of DR1:[NCBI]
Loading Gene Browser...
Protein Sequence
1MASSSGNDDD LTIPRAAINK MIKETLPNVR VANDARELVV
41NCCTEFIHLI SSEANEICNK SEKKTISPEH VIQALESLGF
81 GSYISEVKE VLQECKTVAL KRRKASSRLE NLGIPEEELL
121RQQQELFAKA RQQQAELAQQ EWLQMQQAAQ QAQLAAASAS
161A SNQAGSSQ DEEDDDDI
结构预测来自 AlphaFold DB(UniProt: Q01658),颜色表示 pLDDT 置信度(深蓝高、黄橙低)。
SNP variants of DR1:           Showing partial SNPs
rs771465       rs1062895       rs1062896       rs1062897       rs1062899       rs1323627       rs1323628       rs2031223       rs3067470       rs3087457       rs3087458       rs6679630       rs6690225       rs6693904       rs10782959       rs11164910       rs11164911      

Tissue expression of DR1:    [UniProt]

Gene expression across tissues
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
AAGACCATCTCACCAGAGC
59
GATGTAAGAGCCAAATCCCA
58
TCCCTTGTTTCTTACCCTGAC
60
TGTTGCTGTCTAGCCTCTC
59
CCTGAAGAAGAGTTATTGAGACAG
59
TGCTTGTTGCTGTCTAGCT
60
AAGACCATCTCACCAGAGC
59
GATGTAAGAGCCAAATCCCA
58
CATCTCACCAGAGCATGTC
58
CACTGATGTAAGAGCCAAATCC
60
CTGAAGAAGAGTTATTGAGACAGC
60
TGCTTGTTGCTGTCTAGCT
60
CCCTTGTTTCTTACCCTGAC
58
TGTTGCTGTCTAGCCTCTC
59
CATCTCACCAGAGCATGTC
58
CACTGATGTAAGAGCCAAATCC
60
CCAGAGCATGTCATACAAGC
59
TTACTTCACTGATGTAAGAGCC
58
CATCTCACCAGAGCATGTC
58
ACTGATGTAAGAGCCAAATCC
58
Transcription Factors
Target Gene
Interaction Type
PubMed References
BTAF1
DR1
Repression
DR1
NR1I2
Activation
DR1
NR2C2
Unknown
DR1
PTGS2
Activation
DR1
TBP
Repression
DR1
TBP
Unknown
NR2F1
DR1
Repression

Subcellular localization of DR1 (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for DR1:

GO ID
Protein
Source DB
GO:0000122
Q01658 (UniProtKB)
TAS
GO:0003677
Q01658 (UniProtKB)
IEA
GO:0003714
Q01658 (UniProtKB)
TAS
GO:0005515
Q01658 (UniProtKB)
IPI
GO:0005634
Q01658 (UniProtKB)
IDA
GO:0005671
Q01658 (UniProtKB)
IDA
GO:0006351
Q01658 (UniProtKB)
IEA
GO:0008134
Q01658 (UniProtKB)
TAS
GO:0017025
Q01658 (UniProtKB)
IDA
GO:0043966
Q01658 (UniProtKB)
IDA
GO:0046982
Q01658 (UniProtKB)
IEA

microRNAs potentially regulating DR1:     

String
BioGrid
IntAct
mentha
MINT
Reactome
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
Neuroblastoma 0.00272435 1 0 LHGDN
Alzheimer's Disease 0.002367032 1 0 GAD
MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model.
Gosse JT, Skelton CS, Tremblay ML, Wyatt H, Gonzalez V, Dawod B, Nuschke A, Davis C, Dirk B, Vila-Leahey A, Mackay A, Bobbitt K, West A, Vanderhyden B, Weir G, Merkx-Jacques A, Stanford M, Hrytsenko O, Brewer KD Npj Imaging 2026-04-09
G4-Ligand-Directed PROTACs Unveil DR1 as a Novel Ligand-Co-Binding G4-Protein and Reshape G4-Dependent Transcription.
Li ML, Xu SM, Jiang XC, Dai LT, Hu YT, Wang KB, Tan JH, Huang ZS, Chen SB Adv Sci (Weinh) IF: 9.034 2026-05-00
A generalizable eye disease detection method based on Zero-Shot Learning.
Pan C, Wang Y, Jiang Y, Su Y, Liao M, Lu Y, Li W, Huang Y, Luo Y, Zhang X, Qi H, Gao W Commun Med (Lond) IF: 7.4 2026-03-12
Rheumatoid Arthritis Management: Emerging Drug Therapies and Innovations.
Dushyant, Narwal S, Singh G, Kaur T, Dhingra AK, Grewal N, Jangra G Curr Drug Targets IF: 3.5 2026-03-10
Single-Cell and Mendelian Randomization Analyses Identify Key Genes Common to COVID-19 and Multiple Sclerosis.
Chen S, Ruan J, Cheng S, Zheng H, Chang T, Bao G, Zhu Z, Li X, Zhao W, Zheng K Viral Immunol IF: 1.5 2026-05-00
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.
Aparicio B, Silva L, Ruiz M, Llópiz D, Repáraz D, Theunissen P, Tamayo I, Egea J, Igea A, Smerdou C, Peñas M, Perpiñá C, Matilla A, Varela M, Reig M, de la Torre-Alaez M, Argemí J, Sangro B, Hervás-Stubbs S, Sarobe P Oncoimmunology IF: 6.2 2026-12-31
Leveraging machine learning to predict de novo skin malignancy following lung transplantation.
Nosoudi N, Zadeh A, Nichols R, Kiani C, Ramirez-Vick JE Lung Cancer Manag 2026-12-00
HLA DRB1*01:02 allele is associated with anti-AT1R antibodies production in kidney transplanted patients.
Carelli I, Romano A, Faini AC, Caorsi C, Togliatto GM, Rosso CM, Mazzola G, Garino E, Alizzi S, Magistroni P, Biancone L, Cantaluppi V, Vaisitti T, Deaglio S, Amoroso A Hum Immunol IF: 2.1 2026-06-00
Molecular insights into domestic cat hepatitis B virus linking genome to function.
Šolaja S, Milićević V, Glišić D, Radalj A, Đurić M, Knežević A, Nišavić J Vet Res Commun IF: 2.2 2026-05-02

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com